A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma

Michael W. Brown1, Holly Ning1, Barbara Arora1, Paul S. Albert2, Matthew Poggi3, Kevin Camphausen1, Deborah Citrin1
1Radiation Oncology Branch, CCR, National Institutes of Health, Bethesda, MD
2Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Institutes of Health, Bethesda, MD
3Radiation Oncology, National Naval Medical Center, Bethesda, MD

Tài liệu tham khảo

Landis, 1998, Cancer statistics 1998, Cancer, 48, 6 2003, Cancer facts and figures 2003 Morohoshi, 1996, Exocrine pancreatic tumors and their histological classification, Histopathology, 7, 645, 10.1111/j.1365-2559.1983.tb02277.x Howard, 1977, Cancer of the pancreas, Curr Probl Cancer, 2, 5, 10.1016/S0147-0272(77)80001-9 Brooks, 1983, Cancer of the pancreas, 263 Rosenberg, 1985, Cancer of the head of the pancreas, J Surg Oncol, 28, 217, 10.1002/jso.2930280315 Connolly, 1987, Survival in 1001 patients with carcinoma of the pancreas, Ann Surg, 206, 366, 10.1097/00000658-198709000-00015 Singh, 1990, Surgical palliation for pancreatic cancer. The UCLA experience, Ann Surg, 212, 132, 10.1097/00000658-199008000-00003 Funovics, 1989, Current trends in the management of carcinoma of the pancreatic head, Hepatogastroenterology, 36, 450 Rich, 1998, Radiation therapy for pancreatic cancer, 281 Rich, 1995, Preoperative combined modality therapy for pancreatic cancer, World J Surg, 19, 264, 10.1007/BF00308636 Griffin, 1990, Patterns of failure after curative resection of pancreatic carcinoma, Cancer, 66, 56, 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO;2-6 Moertel, 1981, Therapy of locally unresectable pancreatic carcinoma, Cancer, 48, 1705, 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4 Roldan, 1988, External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer, Cancer, 61, 1110, 10.1002/1097-0142(19880315)61:6<1110::AID-CNCR2820610610>3.0.CO;2-6 Gunderson, 1987, Intraoperative and external beam irradiation +/− 5-FU for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 13, 319, 10.1016/0360-3016(87)90005-8 Mohiuddin, 1995, Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas, J Clin Oncol, 13, 2764, 10.1200/JCO.1995.13.11.2764 Garton, 1993, High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer, Int J Radiat Oncol Biol Phys, 27, 1153, 10.1016/0360-3016(93)90537-6 Shipley, 1984, Intraoperative radiation therapy for patients with pancreatic carcinoma, World J Surg, 8, 929, 10.1007/BF01656034 Shipley, 1980, Iodine-125 implant and external beam irradiation in patients with localized pancreatic carcinoma, Cancer, 45, 709, 10.1002/1097-0142(19800215)45:4<709::AID-CNCR2820450416>3.0.CO;2-5 Mohiuddin, 1988, Combined modality treatment of localized unresectable adenocarcinoma of the pancreas, Int J Radiat Oncol Biol Phys, 14, 79, 10.1016/0360-3016(88)90054-5 Landry, 2002, Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA), Med Dosim, 27, 121, 10.1016/S0958-3947(02)00094-8 Ben-Josef, 2004, Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer, Int J Radiat Oncol Biol Phys, 59, 454, 10.1016/j.ijrobp.2003.11.019 Higgins, 1995, Three-dimensional conformal pancreas treatment, Int J Radiat Oncol Biol Phys, 31, 605, 10.1016/0360-3016(94)00380-4 Li, 2005, Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer, Int J Radiat Oncol Biol Phys, 61, 1251, 10.1016/j.ijrobp.2004.11.034 Guerrero, 2005, Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer, Int J Radiat Oncol Biol Phys, 62, 933, 10.1016/j.ijrobp.2004.11.040 Dogan, 2003, Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing, Int J Radiat Oncol Biol Phys, 57, 1480, 10.1016/S0360-3016(03)01569-4 Guerrero, 2004, Simultaneous integrated boost for breast cancer using IMRT, Int J Radiat Oncol Biol Phys, 59, 1513, 10.1016/j.ijrobp.2004.04.007 Wu, 2003, Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas. I, Int J Radiat Oncol Biol Phys, 56, 573, 10.1016/S0360-3016(02)04617-5 Fu, 2004, Comparison of conformal and intensity-modulated techniques for simultaneous integrated boost radiotherapy of upper esophageal carcinoma, World J Gastroenterol, 10, 1098, 10.3748/wjg.v10.i8.1098 Pinheiro, 2000 Allen, 2004, Adjuvant therapy in pancreatic cancer, Int J Radiat Oncol Biol Phys, 59, 1461, 10.1016/j.ijrobp.2004.01.015 Morganti, 2004, 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma, Int J Radiat Oncol Biol Phys, 59, 1454, 10.1016/j.ijrobp.2004.01.035 Eisbruch, 2002, Intensity-modulated radiation therapy for head and neck cancer, Semin Radiat Oncol, 12, 238, 10.1053/srao.2002.32435 Zelefsky, 2002, Intensity-modulated radiation therapy for prostate cancer, Semin Radat Oncol, 12, 229, 10.1053/srao.2002.00000 D’Souza, 2005, Feasibility of dose escalation using intensity-modulated radiotherapy in posthysterectomy cervical carcinoma, Int J Radiat Oncol Biol Phys, 61, 1062, 10.1016/j.ijrobp.2004.07.721 Gierga, 2004, Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions, Int J Radiat Oncol Biol Phys, 58, 1584, 10.1016/j.ijrobp.2003.09.077 Ozhasoglu, 2002, Issues in respiratory motion compensation during external-beam radiation therapy, Int J Radiat Oncol Biol Phys, 52, 1389, 10.1016/S0360-3016(01)02789-4 Dehnad, 2003, Clinical feasibility study for the use of implanted gold seeds as reliable positioning markers during megavoltage irradiation, Radiother Oncol, 67, 295, 10.1016/S0167-8140(03)00078-1 McGinn, 2001, Phase I trial of radiation dose escalation with concurrent weekly full-dose Gemcitabine in patients with advanced pancreatic cancer, JCO, 19, 4202, 10.1200/JCO.2001.19.22.4202